Shejin Zhu

Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents.

E. LaVoie, Shejin Zhu, Alexander L. Ruchelman, 2005, Bioorganic & Medicinal Chemistry.

6-Substituted 6H-dibenzo[c,h][2,6]naphthyridin-5-ones: reversed lactam analogues of ARC-111 with potent topoisomerase I-targeting activity and cytotoxicity.

E. LaVoie, Shejin Zhu, Alexander L. Ruchelman, 2006, Bioorganic & medicinal chemistry.

Mechanism of Resistance of Hepatitis C Virus Replicons to Structurally Distinct Cyclophilin Inhibitors

X. Puyang, Shejin Zhu, D. Poulin, 2010, Antimicrobial Agents and Chemotherapy.

Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.

E. LaVoie, Shejin Zhu, Alexander L. Ruchelman, 2004, Bioorganic & medicinal chemistry letters.

Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.

E. LaVoie, Shejin Zhu, Alexander L. Ruchelman, 2004, Bioorganic & medicinal chemistry letters.

Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase.

R. Jain, Daniel J. Poon, Shejin Zhu, 2015, Bioorganic & medicinal chemistry letters.

Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design.

A. Fanidi, Yu Ding, B. Appleton, 2016, Journal of medicinal chemistry.